Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pager Alert! Pager Alert! BZZZZTTTTT!!!! BZZZZTTTTT!!! Chirp! Chirp!
.0013 on bid! You did it! Pulling your bids pays!
Stick with Savior and you will save money!
PVSP minority owned KRTL Biotech NEW Ticker & Name
New Tweet about new NAME and Ticker to be announced.
PVSP should be changed shortly also to reflect Artizen Cannabis according to German.
See new Tweets
Conversation
KRTL HOLDING GROUP
@KRTL1111
Attention QENC shareholders: we are nearing the completion of the companies ticker and name change. Other announcements to come.
11:56 AM · Jul 20, 2022·Twitter for iPhone
In 2 days Cannabis up 40%
Many, many of the Cannabis stocks are already up 40% in 2 days.
It took 6 months to drop them to lows, and then BLAM!
PVSP will takeoff soon, the conversions may slow us down a little, but it will happen.
PVSP investment in KRTL Biotech Up 22% today
We have to move soon, and the chasing will begin!
Market is putting in a Bottom as we speak!!
Markets are way over sold as is PVSP.
PVSPReversal will come soon, just a matter of time.
Cannabis stocks on FIRE again!!
Trulieve up 8%
Tilray up 11%
Sundial up 9%
Medical Mj up 15%
Aurora up 11%
Canopy Growth up 17%
Growlife up 10%
CBD Denver up 18%
and many more. PVSP will move back up any minute!
Still Growing Every Day! Let's Rock $PVSP
Hahaha ..
That what I said when the pumpers were selling hopium on January
I said this POS company will drag you with the rotten carrot the the rest of the 2022 with only one target: keep you from selling
Then you will find 2023 printed as the new target of their rotten carrot
Do I see 2023 on this post?
Lololol .. next 2024 :)
Lolololo
Zen .. $$$ .. to the moon
Phoenix rising
BS .. Nonsense ..
because our legislatorts draging there feet others wont I guess
but nancy can load on NVDA and push for 52B semiconductor bill in congress...that is all legal...banking 13% on that so far
ho
Posting the only positive news this stock has over and over again while ignoring the fact that the SP is in the toilet and almost at the new 52 week low... is worse than what could perceived as bashing.
The SP just hit a new 52W Low for a reason.
Still overvalued.
Trips are almost here.
His numbers are always goofy. A fixed amount of shares priced at $.001 were issued for one note. Another note had a $.0025 conversion - priced higher than the current price.
A 24 month roadmap is about to be released by management which should be a good update for long-term shareholders.
As stated during the investor conference, the new revenues and full impact of the expense reduction will hit in Q3/4 and all of 2023.
Germany to become worlds largest market
Just out today, check out the video on what Germany expects from Cannabis!!
Cheapies... all this stock does is go down for over a year... get your cheapies LOL. Best joke yet.
Still overvalued. Get some low lowwwwwww trips. That's cheapies.
MM want to hold the ASK
That is how you can tell the conversion is active. They offer those shares on the ASK (which are Shorted) to get seller to take the .0014. At the end of the day they use the conversion share that they have in hand, to cover those shorted .0014, and walk away with the 1 or 2 tics, which is perfectly legal and acceptable, as they are taking some risk and getting shares sold without crashing the price too much.
And suddenly the 5 million share offering disappeared…
We may have to pay the ASK
If the conversion gift is done, we may have to pay up to the ASK.
Don't anyone complain if it starts moving back up, everyone had their chance to buy the super cheapies.
That could be the last of the Conversion
14M conversion, with total traded of 18M, leave only 4M real trades.
Converter was limited to 3-5% of daily volume in the past.
LOL if you want goofy numbers, just wait for the audit.
There is the conversion, 10M + 4M
So basically all the selling is just conversion, only 4M real trades, no real sellers!
Maybe German lifted the restriction on amount allowed to be converted and told to just get it done.
Say What? LOL
What are you talking about, seriously you are too funny. What are those goofy numbers ?
The conversion is fixed amount, it doesn't matter to PVSP what price the converter sells them, it give shareholder the opportunity to pick up cheap shares in the open market.
What's not to like?
Right - at the rate of $135,000 per quarter (= 135 million shares dumped), $3 million will get paid in about 22 years. The company isn't making enough money to keep even one nostril above water, let alone pay off debt through net losses.
The Freedom deal results seen Q3 & Q4
RYE BROOK, N.Y., May 13, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, and Zen Asset Management, owners of the Artizen brand (jointly referred to as “Artizen”) today announced that it has formed a strategic relationship with Canada based Freedom Cannabis to pursue mutually beneficial business opportunities.
The strategic relationship will see the two companies collaborate on areas of mutual benefit, including co-branding and sharing intellectual property. The two companies entered into the relationship after signing a non-binding Letter of Intent that forms the basis of the agreement.
“Freedom and its management team have an impressive foundation for growth, and we are pleased to enter into this relationship, maximizing each other’s potential, especially at a time when we are expanding Artizen across the United States. Building on the recognition of Artizen as the 9th largest independent cannabis flower brand in the US, Freedom is the perfect strategic partner to both accelerate our growth and enter the Canadian market,” said German Burtscher, Pervasip’s President and Chief Executive Officer.
The strategic relationship is beneficial to both companies as they build brand awareness in their respective markets. The cannabis companies are licensed producers and managers of premier brands and are quickly gaining market share in both Canada and the US. The LOI also contemplates a potential joint venture between the two companies for Artizen branded product to be grown at the Freedom facility located just outside of Edmonton, Alberta. This would include licensing of the Artizen brand in Canada and Freedom licensing its brand to Artizen in the US.
Converting Debt is always good. LOL
Good to see you know what debt conversion look like, nothing to do with dumping stock. Smooth and orderly conversion with fixed number of shares, no price adjustments.
The KRTL deal is important for PVSP
The KRTL deal is very important to prove the efficacy of our products for the wellness business. Could also lead to medical mj products in the future, IMO.
“We look at this as another step in supporting our development of market disrupting wellness products and distribution.”
Pervasip is pleased to announce that it, and Dr. Kyeung-Il Park, a KRTL Biotech Inc. team member, have received an agreement by the Hemp Regulation Free Special Zone Project Promotion Team in Kyeongbuk Institute for Bio Industry, a local public enterprise, (http://gib.re.kr/about/major/major2), and both KRTL International Corp., and Artizen Corporation have been hired by Dr. Kyeung-il Park to act as exclusive consulting groups to provide services and support for the development of indoor smart growing, one of three core strategic areas of interest in development for the Korean CBD industry regulations sector.
Korea has committed $40 million to assist in the development of this emerging industry. They are funding various greenhouse trials, research, policy development and testing efforts.
“We are excited about the opportunity to work with KRTL on this project. It allows us to become trusted partners in what will become a true center of excellence for developing CBD/Hemp opportunities throughout Asia,” says German Burtscher, the company’s President & CEO. “We look at this as another step in supporting our development of market disrupting wellness products and distribution.”
https://finance.yahoo.com/news/pervasip-krtl-international-receive-exclusive-131500920.html
Might as well feed all that weed to the cows.
More conversions, more dumping at a feverish, crazed level, in fear that buying support will fade out.
More support for your opinion:
https://www.wweek.com/news/2022/07/13/demand-for-cannabis-in-portland-falls-to-a-three-year-low/
Oldrogue.
Savior here.
It wouldn't be the first time I led my followers to a dry hole, but stick with me. I am consulting the Ancient Scrolls. In time, all will be revealed.
So no profits and debt conversions causes stock prices to go down? Seems no one knew.
Overvalued!
Better tell Bezos. Amazon lost $3.8M in profits in one Q.
https://www.forbes.com/sites/shelleykohan/2022/04/28/amazon-loses-38-billion-in-profits-but-andy-jassy-is-not-concerned/
Artizen is doing all the right things cutting costs and increasing revenues in Q3 and Q4 and all of 2023. This was explained in the recent corporate presentation if you watched it. Did you?
Nobody cares about revenue. It's profits and debt paydown that matter.
This thing really needs the MOALOIs. (Mother of All Letters of Intent). What a joke. When is the reverse split?
I thought that was pretty funny too. Almost like a Sandy Winick special. I think Sandy is still in a Vietnamese prison somewhere for child sex.
More and more debt and convertibles. Debt worth .00001/share. Over $2 million of debt. That's 200 billion shares.
Losses = 30% of revenues. While I applaud the accountants for their bravery, its obvious they aren't putting meat on their table. Or anyone else's.
You think a stock can be "undervalued" for over 2 years?
There's a reason why the SP is where it is. Can't blame the market... cannabis stocks are up. Not 52W lows today.
$PVSP I Disagree still way undervalued. Market cap not even at half of yearly revenues
New 52 week low is in and still OVERVALUED.
Trips here we come!
Reform in some form is going to happen. The reason the entire cannabis sector tanked was the previous lack of action by Congress. Artizen’s financial restructuring will be recognized for the next couple of years. At least they were proactive in this area.
Reform is the catalyst the to the overall market. It’s coming imo.
Cannabis Companies are on FIRE again!!
Trulieve up 5%
Tilray up 10%
Sundial up 5%
Green Globe up 17%
MineMed up 7%
Aruora up 10%
Canopy growth up 19%
Growgeneration up 8%
Senate will be looking several Bills in next 2 weeks that would decriminalize cannabis and allowing access to Fed Banking system, both of which are Game Changer for us.
Artizen is doing all the right things in a challenging cannabis market. The entire
Market is adjusting. The restructuring will pay dividends for long-term shareholders throughout 2022 and all of 2023.
Need the audited financials and name change. Pervasip needs to go.
LOL "Right of Use Assets" - is that a KK thing?
How does a 250:1 R/S work for you?
Pager Alert! Pager Alert! BZZZZTTTTTT!!! BZZZZTTTTTT!!
Resetting pager for .0011
That is all.
Guess all those months of silence (while restructuring and 'working behind the scenes') could have been MORE effectively used messaging those efforts to the market. Who could have predicted that? Who indeed?
Guess I'll sink the nets even lower.. now the new 52 w. low just punched in and it's just gonna be another year or two. Kinda suspected I'd get a chance to reload in the trips.
Guess being 'diamondhanded' isn't always the smartest play.. sometimes it makes sense to listen to the honest longs (weak handed bastards that 'we' are).
Active Trader Pro BannerPrint Print
A A A
All Content and Data provided by Third-Parties — Terms of Use
Pervasip Announces 2nd Quarter Financials
GLOBENEWSWIRE 9:00 AM ET 7/18/2022
Symbol Last Price Change
PVSP 0.0015down -0.0001 (-6.25%)
QUOTES AS OF 10:08:44 AM ET 07/18/2022
SEATTLE, July 18, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp.(PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced the filing of its unaudited financial statements for its 2nd Quarter ended May 31, 2022.
The cannabis market on the Westcoast has seen a dramatic post pandemic retraction and created a challenging environment for all producer, processors and retailers. With an almost 18% contraction in retail revenues, massive oversupply and increasing costs, the industry has rushed head on into a perfect storm.
“Our systemwide restructuring launched end of 2021, the strength of the Artizen flower brand supported by our amazing independent cultivators, and several aggressive new initiatives have allowed us to be in a much better position than most of our competitors. Q2 financials reflect economic realities from increased expenses as well as a material investment into an aggressive market capture plan. Recognizing the economic headwinds being extremely strong, and competitors struggling, we decided in March on an aggressive strategy to go after market share and repriced in late April the classic Artizen brand at a lower shelf price and implemented an aggressive sales and marketing plan,” says German Burtscher, Pervasip’s CEO & President. “With strong surplus inventory coming out of Q1 the company is using wholesale channels to generate the cash needed to pursue this strategy, albeit at extremely low margins, yet allowing for cashflow positive operations. This is the time when established brands like Artizen show their strength and with aggressive and creative responses take advantage of their brand equity to gain additional market share. In many ways, this is reminiscent of the market contraction during 2017/18.”
The Company is adding key value products to its portfolio and is launching a new craft brand in September. During the last 6 months, the Company also executed on its Korea CBD strategy, launched Artizen Wellness, a global initiative, and added new product lines that are immediately revenue producing and are projected to reach $10 – 12 million in annualized sales by the end of the year, with $2.5 million in annualized revenues already being realized for July 2022.
With additional new product lines coming online over the next 3 – 4 months and further restructuring of expenses, the Company is poised for a positive 3rd and 4th quarter with annualized revenues reaching a conservative $21 million.
“We will also pursue additional restructuring efforts to strengthen shareholder value as it relates to our capital structure,” says German Burtscher. “We will report on those and provide a detailed 24 months company roadmap within the next few weeks.”
Second Quarter 2022 Financial Results
With an 18% general market contraction, and after repricing the Artizen brand at a lower price range and increasing wholesale volume from inventory to generate needed cash, revenue for Q2 was lower compared to Q2 2021. Adjusted inventories added COGs expenses and the Company also chose to reprice certain inventories which added another $225,000 in COGs.
Q2 21/22 Q2 20/21
Revenue $ 3,684,433 $ 4,384,331
COGs $ 3,514,094 $ 2,918,309
Inventory Adjustment $ 394,743 $ (343,246 )
Unadjusted COGs $ 3,119,351 85 % $ 3,261,555 74 %
Unadjusted EBIDTA COGs $ 2,855,647 78 % $ 2,922,695 67 %
Net loss attributable to Pervasip Corp(PVSP) for the period ended May 31, 2022 increased to $(433,279) from $128,915 for the period ended May 31, 2021
Key Highlights
Answering tough cannabis market conditions, the Company has chosen an aggressive strategy to capture market share, projecting several competitors to exit the market and Artizen adding shelf space
Utilizing surplus inventory from increased yields, the Company is generating needed cash through low priced wholesale channels
Additionally, the Company added a new product vertical via a strategic partnership for rollout of $12 million annual vape and concentrates vertical with first brands launched in July 2022
Announced a strategic partnership with one of Canada’s most well-known cannabis companies, Freedom Cannabis, and is in the process of licensing the Artizen brand for rollout in all major Canadian provinces
Launched Artizen Wellness, a non-THC, CBD/terpene focused wellness line that will disrupt the global wellness market
The Company is also pursuing additional operational, financial and legal restructuring to further clean and strengthen its balance sheet.
A reported default on a new lease agreement is being cured and the final arrangement will be reflective of new market conditions
Pervasip Corporation (PVSP)
Pervasip Corp. (PVSP), a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip(PVSP) additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com. Additional information on Pervasip(PVSP) can be found at www.pervasip.net.
Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as may, would, could, will, likely, except, anticipate, believe, intend, plan, forecast, project, estimate, outlook, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments; ability to retain its key personnel; the intention to grow the Company’s business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company. Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; and the Company’s ability to secure financing on reasonable terms. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company’s periodic disclosure statements. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
For further information, please contact:
T: 206-590-2408, Extension 102
E: info@pervasip.net
Image: https://www.globenewswire.com/newsroom/ti?nf=ODYwMDk1MSM1MDQzNjk5IzUwMDEwMTE4OA==
Image: https://ml.globenewswire.com/media/OTRiNzFmMDItM2ExYy00M2IwLWE5MTEtZWZiZjE3YzI5ZDE1LTUwMDEwMTE4OA==/tiny/Pervasip-Corp-.png
Image: Primary Logo
Source: Pervasip Corp.(PVSP)
2022 GlobeNewswire, Inc.
Followers
|
856
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
183602
|
Created
|
10/04/08
|
Type
|
Free
|
Moderators jobynimble DSherman allenc Urocka |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |